SiteOne Therapeutics Garners $1,500,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=66661bbc-d22d-4fe6-aac5-e8bf07fafdf2 - Date
9/25/2014 - Company Name
SiteOne Therapeutics - Mailing Address
953 Indiana Street San Francisco, CA 94107 USA - Company Description
SiteOne Therapeutics, located in San Francisco, is developing novel therapeutics and diagnostics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids. - Website
http://www.site1therapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$1,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes will be used to advance its oral Na?1.7 inhibitor program for pain and to further develop its technology platform for long-acting local analgesics, pain diagnostics and other pain indications. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
